MUSCLE, GROWTH & RECOVERY
A 29-amino-acid peptide functionally identical to the body's own growth-hormone-releasing hormone (GHRH).
Sermorelin is a research peptide functionally identical to the body's own GHRH. It is one of the most studied and cleanest approaches to stimulating natural GH and IGF-1 release, working with the body's own pulsatile rhythm rather than overriding it. It has an extensive clinical history and prior regulatory approval.
Included because it has an extensive clinical research history and prior regulatory approval, works through a well-characterized GHRH-receptor mechanism, and has a long, consistent track record of research use. It anchors the established end of the GH-axis research spectrum.
Binds the pituitary GHRH receptor and stimulates the body's own pulsatile GH release, described as mimicking a younger physiological pattern.
Described as producing no suppression, no cortisol or prolactin spike, and no desensitization with appropriate cycling.
WHAT THE RESEARCH MEASURED
Findings describe study outcomes, not expected personal results.
Sermorelin was previously FDA-approved and later withdrawn from the U.S. market for commercial (not safety) reasons. Material offered here is sold and offered strictly for laboratory and research use.
